# An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

> **NCT06444412** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 25 (estimated)

## Conditions studied

- WHO Grade 3 Glioma
- WHO Grade 4 Glioma

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **DRUG:** Ga 68 PSMA-11
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT06444412
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-12
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06444412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06444412, "An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06444412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*